Home -> Law Blog Directory -> Intellectual Property Law Blogs -> FileWrapper
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: FileWrapperPublic use can't be experimental if not for purposes of the patent application
By McKee, Voorhees & Sease, P.L.C.
In a decision last week, the Federal Circuit affirmed a district court's grant of summary judgment of invalidity of a patent and summary judgment to the defendant on the Plaintiff's false advertising claims. The defendant asserted the patent was invalid as obvious and by virtue of a prior public use. The district court held a genuine issue of fact existed regarding whether the public use was experimental, but granted summary judgment of obviousness. The court also granted summary judgment on the false advertising claims.
The Federal Circuit agreed the patent was invalid, but on the grounds of public use. Specifically, the court held there was no genuine issue of material fact that the public use both embodied all the claim limitations and was not for experimental use. While the purpose of the use was ostensibly for purposes of durability testing, the court observed that the results of the "test" (which was performed in 1989) were not available until almost a year after the patent application was filed in 1992. As such, even if the use was for purposes of testing durability, it could not, as a matter of law, be experimental use, because it was not for purposes of the patent application.
The court also affirmed the summary judgment on the Lanham Act false advertising claims, agreeing with the district court there was no evidence the two challenged statements were false.
More detail of Clock Spring, L.P. v. Wrapmaster, Inc. after the jump.
[More]
Full post as published by FileWrapper on April 02, 2009 (boomark / email).
Visa Applications For Foreign Nationals Married to American Citizens
two options for getting your foreign-born spouse a visa
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Citizenship and Immigration Canada
allegedly overcharged for immigration application fees.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory
Nursing Home Abuse
New Data Made Public

Video Introduction to Experimental Philosophy
Apple makes new pattent application public
Tax Compliance and Voluntary Public Good Provision
Outsourcing of Patent Preparation: PTO Says Beware
Patent Prosecution Highway Programs Streamline Global Patent Process
Patent Against Trolls a Social Commentary









